Proactive Investors - Run By Investors For Investors

Orgenesis to present at Biotech Showcase in San Francisco next week

Orgenesis Inc (NASDAQ: ORGS) Director of Business Development Robert Beckman tells Proactive Investors the cell therapy company's CEO Vered Caplan will speak on a panel entitled “Cell and gene therapy: The financing surge” at the Biotech Showcase in San Francisco next week.

Beckman says the apparent interest in cell and gene therapies have become strong, as unparalleled amounts of money have been raised in the sector. Beckman says Orgenesis stands to differentiate itself among other cell therapy companies as being one of the 'most prolific collaborators' in the cell therapy sector.

 
View full ORGS profile View Profile

Orgenesis Timeline

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use